Human Formulations Portfolio

Finished Pharmaceutical
Formulations

Explore Decure’s sourcing portfolio across injectables, tablets, capsules, dry syrups, topical formulations and specialized therapeutic ranges, with multiple strengths, compositions and dosage-form options for institutional and commercial requirements.

8+Product Categories

500+Product Variants

MultipleDosage Forms

GMPQuality Sourced

Clear Filters
RFQ List (0)
Human Formulations

532 products available

Page 19 of 22

CapsulesSingle

Rosuvastatin 10mg + Clopldogrel 75mg capsules

Capsule

Rosuvastatin 10mg + Clopldogrel 75mg capsules is a capsule formulated with Rosuvastatin 10mg + Clopldogrel 75mg. The listed active ingredient profile is Rosuvastatin; Clopldogrel, placing the product in the cardiovascular category. The formulation contain

Available strengths
Rosuvastatin 10mg + Clopldogrel 75mgRosuvastatin 20mg + Clopldogrel 75mg
Cardiac RangeSingle

Rosuvastatin 10mg Tab. (Film Coated)

Tablet

Rosuvastatin 10mg Tab. (Film Coated) is a tablet formulated with Rosuvastatin 10mg . ( ). The listed active ingredient profile is Rosuvastatin, placing the product in the lipid-lowering therapy category. The formulation contains lipid-lowering medicine(s)

Available strengths
Rosuvastatin 10mg . ( )Rosuvastatin 20mg . ( )
Cardiac RangeSingle

Rosuvastatin 10mg, Aspirin 75mg + Clopidogrel 75mg Capsules

Capsule

Rosuvastatin 10mg, Aspirin 75mg + Clopidogrel 75mg Capsules is a capsule formulated with Rosuvastatin 10mg, Aspirin 75mg + Clopidogrel 75mg. The listed active ingredient profile is Rosuvastatin; Aspirin; Clopidogrel, placing the product in the antiplatele

Available strengths
Rosuvastatin 10mg, Aspirin 75mg + Clopidogrel 75mgRosuvastatin 20mg, Aspirin 75mg + Clopidogrel 75mg
Topical FormulationsSingle

Salicylic Acid 6%w/w

Topical Formulation

Salicylic Acid 6%w/w is a topical formulation formulated with Salicylic Acid 6%w/w. The listed active ingredient profile is Salicylic Acid w/w, placing the product in the keratolytic / dermatology category. The formulation contains keratolytic ingredients

Available strengths
Salicylic Acid 6%w/wSalicylic Acid 12%w/wSalicylic Acid 27%w/w
Topical FormulationsSingle

Sertaconazole Nitrate 2% w/w Benzyl Alcohol 1%w/w

Topical Formulation

Sertaconazole Nitrate 2% w/w Benzyl Alcohol 1%w/w is a topical formulation formulated with Sertaconazole Nitrate 2% w/w Benzyl Alcohol 1%w/w. The listed active ingredient profile is Sertaconazole Nitrate % w/w Benzyl Alcohol w/w, placing the product in th

Available strengths
Sertaconazole Nitrate 2% w/w Benzyl Alcohol 1%w/w
Topical FormulationsSingle

Sertaconazole Nitrate IP 2%w/w + Benzyl Alcohol 1%w/w Cream

Cream

Sertaconazole Nitrate IP 2%w/w + Benzyl Alcohol 1%w/w Cream is a cream formulated with Sertaconazole Nitrate IP 2%w/w + Benzyl Alcohol 1%w/w. The listed active ingredient profile is Sertaconazole Nitrate w/w; Benzyl Alcohol w/w, placing the product in the

Available strengths
Sertaconazole Nitrate IP 2%w/w + Benzyl Alcohol 1%w/w
Diabetic RangeSingle

Siaglipin 50 mg + Dapagliflozin propanedlol monohydrate Eq to dapaglilozine 10mg (Film coated tab)

Tablet

Siaglipin 50 mg + Dapagliflozin propanedlol monohydrate Eq to dapaglilozine 10mg (Film coated tab) is a tablet formulated with Siaglipin 50 mg + Dapagliflozin propanedlol monohydrate Eq to dapaglilozine 10mg ( ). The listed active ingredient profile is Si

Available strengths
Siaglipin 50 mg + Dapagliflozin propanedlol monohydrate Eq to dapaglilozine 10mg ( )
CapsulesSingle

Silodosin 8 mg + Dutasteride 0.5 mg Capsules (Each Hard Gelatin Capsules)

Hard Gelatin Capsule

Silodosin 8 mg + Dutasteride 0.5 mg Capsules (Each Hard Gelatin Capsules) is a hard gelatin capsule formulated with Silodosin 8 mg + Dutasteride 0.5 mg (Each ). The listed active ingredient profile is Silodosin; Dutasteride, placing the product in the uro

Available strengths
Silodosin 8 mg + Dutasteride 0.5 mg (Each )
CapsulesSingle

Silodosin Capsules 4 mg

Capsule

Silodosin Capsules 4 mg is a capsule formulated with Silodosin 4 mg. The listed active ingredient profile is Silodosin, placing the product in the urology category. The formulation contains medicine(s) used in selected lower-urinary-tract or prostate-rela

Available strengths
Silodosin 4 mgSilodosin 8 mg
Topical FormulationsSingle

Silver Sulphadiazine 1.0%w/w

Topical Formulation

Silver Sulphadiazine 1.0%w/w is a topical formulation formulated with Silver Sulphadiazine 1.0%w/w. The listed active ingredient profile is Silver Sulphadiazine w/w, placing the product in the antiseptic / wound care category. The formulation contains ant

Available strengths
Silver Sulphadiazine 1.0%w/w
Diabetic RangeSingle

Sitagliptin 100 mg + Dapaglilozin propanediol monohydrate Eq to dapagliflozine 10mg (Film coated tab)

Tablet

Sitagliptin 100 mg + Dapaglilozin propanediol monohydrate Eq to dapagliflozine 10mg (Film coated tab) is a tablet formulated with Sitagliptin 100 mg + Dapaglilozin propanediol monohydrate Eq to dapagliflozine 10mg ( ). The listed active ingredient profile

Available strengths
Sitagliptin 100 mg + Dapaglilozin propanediol monohydrate Eq to dapagliflozine 10mg ( )
Diabetic RangeSingle

Sitagliptin Phosphate Monohydrate Eq. To Sitagliptin 50mg + Metformin Hydrochloride 500mg

Tablet

Sitagliptin Phosphate Monohydrate Eq. To Sitagliptin 50mg + Metformin Hydrochloride 500mg is a tablet formulated with Sitagliptin Phosphate Monohydrate Eq. To Sitagliptin 50mg + Metformin Hydrochloride 500mg. The listed active ingredient profile is Sitagl

Available strengths
Sitagliptin Phosphate Monohydrate Eq. To Sitagliptin 50mg + Metformin Hydrochloride 500mg
Diabetic RangeSingle

Sitagliptin Phosphate Monohydrate Eqg. To Sitagliptin 5Omg + Metformin Hydrochloride 1000mg

Tablet

Sitagliptin Phosphate Monohydrate Eqg. To Sitagliptin 5Omg + Metformin Hydrochloride 1000mg is a tablet formulated with Sitagliptin Phosphate Monohydrate Eqg. To Sitagliptin 5Omg + Metformin Hydrochloride 1000mg. The listed active ingredient profile is Si

Available strengths
Sitagliptin Phosphate Monohydrate Eqg. To Sitagliptin 5Omg + Metformin Hydrochloride 1000mg
Diabetic RangeSingle

Sitagliptin Phosphate Tablets 25 mg

Tablet

Sitagliptin Phosphate Tablets 25 mg is a tablet formulated with Sitagliptin Phosphate 25 mg. The listed active ingredient profile is Sitagliptin Phosphate, placing the product in the oral antidiabetic category. The formulation contains one or more oral gl

Available strengths
Sitagliptin Phosphate 25 mgSitagliptin Phosphate 50mgSitagliptin Phosphate 100mg
Topical FormulationsSingle

Sodium Fluride 0.2Tw/w + Triclosan 0.3%w/w

Topical Formulation

Sodium Fluride 0.2Tw/w + Triclosan 0.3%w/w is a topical formulation formulated with Sodium Fluride 0.2Tw/w + Triclosan 0.3%w/w. The listed active ingredient profile is Sodium Fluride .2Tw/w; Triclosan w/w, placing the product in the topical dermatology ca

Available strengths
Sodium Fluride 0.2Tw/w + Triclosan 0.3%w/w
Topical FormulationsSingle

Sodium MonoFluorophosphate USP 0.38%w/w Gel

Gel

Sodium MonoFluorophosphate USP 0.38%w/w Gel is a gel formulated with Sodium MonoFluorophosphate USP 0.38%w/w. The listed active ingredient profile is Sodium MonoFluorophosphate w/w, placing the product in the dental / oral care category. The formulation c

Available strengths
Sodium MonoFluorophosphate USP 0.38%w/w
Topical FormulationsSingle

Sodium Monoflurophosphate 0.387%w/w

Topical Formulation

Sodium Monoflurophosphate 0.387%w/w is a topical formulation formulated with Sodium Monoflurophosphate 0.387%w/w. The listed active ingredient profile is Sodium Monoflurophosphate w/w, placing the product in the topical dermatology category. The formulati

Available strengths
Sodium Monoflurophosphate 0.387%w/w
Cardiac RangeSingle

Spironolactone 100mg Tab. (Uncoated)

Tablet

Spironolactone 100mg Tab. (Uncoated) is a tablet formulated with Spironolactone 100mg . ( ). The listed active ingredient profile is Spironolactone, placing the product in the potassium-sparing diuretic category. The formulation contains a potassium-spari

Available strengths
Spironolactone 100mg . ( )
Human FormulationsSingle

Steroids

Dosage form on request

Synthetic glucocorticoid APIs spanning topical, inhaled, injectable, and systemic formulation grades. Supplied in USP/EP/BP specification to pharmaceutical manufacturers across regulated and emerging export markets.

Available strengths
Steroids
CapsulesSingle

StreptococCus faecalls 30MIlI, Clostrldlum butyricum 2Mill, Bacillus mesentericus 1Mill + Lactic acid Bacillus 50MillCapsulee

Capsule

StreptococCus faecalls 30MIlI, Clostrldlum butyricum 2Mill, Bacillus mesentericus 1Mill + Lactic acid Bacillus 50MillCapsulee is a capsule formulated with StreptococCus faecalls 30MIlI, Clostrldlum butyricum 2Mill, Bacillus mesentericus 1Mill + Lactic aci

Available strengths
StreptococCus faecalls 30MIlI, Clostrldlum butyricum 2Mill, Bacillus mesentericus 1Mill + Lactic acid Bacillus 50MillCapsulee
Topical FormulationsSingle

Sucralfate 70mg + Metronidazole 10mg + Povidone-Iodine 50mg

Topical Formulation

Sucralfate 70mg + Metronidazole 10mg + Povidone-Iodine 50mg is a topical formulation formulated with Sucralfate 70mg + Metronidazole 10mg + Povidone-Iodine 50mg. The listed active ingredient profile is Sucralfate; Metronidazole; Povidone-Iodine, placing t

Available strengths
Sucralfate 70mg + Metronidazole 10mg + Povidone-Iodine 50mg
Topical FormulationsSingle

Sucralfate USP 70 mg + Metronidazole IP 10 mg + Povidone-Iodine 50 mg Ointment

Ointment

Sucralfate USP 70 mg + Metronidazole IP 10 mg + Povidone-Iodine 50 mg Ointment is a ointment formulated with Sucralfate USP 70 mg + Metronidazole IP 10 mg + Povidone-Iodine 50 mg. The listed active ingredient profile is Sucralfate; Metronidazole; Povidone

Available strengths
Sucralfate USP 70 mg + Metronidazole IP 10 mg + Povidone-Iodine 50 mg
Topical FormulationsSingle

Tacrolimus 0.03%w/w

Topical Formulation

Tacrolimus 0.03%w/w is a topical formulation formulated with Tacrolimus 0.03%w/w. The listed active ingredient profile is Tacrolimus w/w, placing the product in the topical anti-inflammatory / dermatology category. The formulation contains topical anti-in

Available strengths
Tacrolimus 0.03%w/w
Cardiac RangeSingle

Tadalafil 10mg + Dapoxetine 30mg Tablets (entertc coated)

Tablet

Tadalafil 10mg + Dapoxetine 30mg Tablets (entertc coated) is a tablet formulated with Tadalafil 10mg + Dapoxetine 30mg (entertc coated). The listed active ingredient profile is Tadalafil; Dapoxetine, placing the product in the sexual health / urology cate

Available strengths
Tadalafil 10mg + Dapoxetine 30mg (entertc coated)
TabletsSingle

Tapentadol Hydrochloride 150 mg + Paracetamol 325 mg Uncoated Tablet

Uncoated Tablet

Tapentadol Hydrochloride 150 mg + Paracetamol 325 mg Uncoated Tablet is a uncoated tablet formulated with Tapentadol Hydrochloride 150 mg + Paracetamol 325 mg. The active ingredient profile is Tapentadol Hydrochloride; Paracetamol, placing the product in

Available strengths
Tapentadol Hydrochloride 150 mg + Paracetamol 325 mg
Add to RFQ

Rosuvastatin 10mg + Clopldogrel 75mg capsules

Add to RFQ

Rosuvastatin 10mg Tab. (Film Coated)

Add to RFQ

Rosuvastatin 10mg, Aspirin 75mg + Clopidogrel 75mg Capsules

Add to RFQ

Salicylic Acid 6%w/w

Add to RFQ

Silodosin Capsules 4 mg

Add to RFQ

Sitagliptin Phosphate Tablets 25 mg

Quality-led sourcing

Why Choose Decure for Human Formulations?

GMP Certified Manufacturers
Wide Product Portfolio
Multiple Dosage Forms
Global Supply Network
Regulatory Documentation
Competitive Pricing
B2B pharmaceutical sourcing

Looking for Specific Formulations or Large Quantities?

Our sourcing experts are ready to help with custom requirements, supply availability and regulatory documentation.

RFQ List (0)